This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Phenomenology and Epidemiology of Childhood Psychiatric Disorders That May Necessitate Treatment With Atypical Antipsychotics

Melissa DelBello, MD, and Stephen Grcevich, MD

Published: April 1, 2004

Article Abstract

Children and adolescents commonly present to clinical settings with more severe psychopathologythan previously recognized. Physicians evaluating children may be confronted with clinical manifestationsof early-onset schizophrenia, including command hallucinations and delusional thinking, severeirritability and suicidality associated with juvenile-onset bipolar disorder, or the severe aggressionof a child with a pervasive developmental disorder. In these as well as other clinical situations,the potential risks and benefits of treatment with atypical antipsychotics should be considered. In thisarticle, we summarize the clinical manifestations of psychiatric disorders in children and adolescents,with particular attention to the disorders for which the benefits of prescribing an atypical antipsychoticmay outweigh the potential risks. We also describe the differences in the clinical presentation of thesedisorders between youth and adults.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Child and Adolescent , Populations

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...